Member Info for GordonGecko123

Yes a great update that's why the SP is down nearly 20% . Talk about deluded ramping .

This has fallen like a brick since it returned to trading and continues to disappoint and head back to all time lows ..some people love flogging a dead horse and seek to be in Dreamland .

What a dog this company is more delays back to sub 5p . Glad I didn't bother when someone tipped this at 18p not so long ago . Utter disaster

Agreed the potential is here however they have been slow to make progress and continue to be slow . They have a much bigger sales team now so we will see if they deliver . I'm still holding but growing impatient at the lack of progress here

The don't need to raise for about a year or can't you read m they have plenty of cash for a year plus based on the current revenues . Any increase will extend the cash runway .

I really wish people would learn to read

Your maths is very wrong . There are just over 1.9bn shares in issue . Our current mkt cap is just over 8m therefore for 100m mkt cap a price of 6p now . Easily achievable if they can sign some revenue deals with any of the major companies they are dealing with .

Director options start at 1.4p then 2p and 2.4p I think 6p is easily achievable sometimes next year . Very undervalued stock and a very comfortable one to hold with a long cash runway and increasing interest

Exactly once might be coincidence twice is making a point . Seems some are slow to pick up on what's happening here . Just glad I have a shed load already tucked away .

Good find . Things are starting to move and FDA for 6-12 due soon . Let's hope it translates into increased revenue and more deals soon . Looks undervalued given FDA clearance and reimbursement codes in place etc . Plenty of cash for 12-18 months and further as revenues grow . All done to sales now

I think you will find the recent rise is due to a seller having been cleared so the share price is recovering m the seller was around a few months hence the drop from 1.8 to 1.2p over that period . Now they are clear the SP will recover hopefully in time for FDA news and other news

That's why you need to be careful which Gordon you listen to then . I expected this would get worse and worse and now today's rns co forms that they are on their last legs . Desperate for cash and with very limited options . I suspect the next rns won't be a nice one either .with admin a high probability again. If they manage to stave that off it will likely come at great cost to current and other long term holders with a dillutive fund raise only postponing the inevitable . They can't make the discs reliably or efficiently . Today's performance figures of 52-78% are shocking . They have spent the better part of 40m trying to sort production issues out and failed . Revenues are far too low too .

More bad news incoming here very soon one way or another imo

Total disaster next rns will be a very bad fund raise or admin imo . Should have fallen further on that rns it was abysmal and shows how close they are to complete failure now .

OEMs getting their discs while working on other solutions imo not supportive just looking after their own interests having seen the mess this company is

This is a longer term process for polx won't see much in way of revenue until it gets regulatory approval hence the USA market is still key near term and they need to be getting sales signed up asap to extend the cash runway . They took on 5 sales people late last year . They need to be delivering sales soon

Cleared finally and coincide with some news . FDA news is due aswell as sales news soon . Will be back at 2p in no time

There has been a seller around for some time dragging the price down m they look to have been clea

This has gone under the radar . In the note is says talks are well under way and apta looking for high single digit royalty . They are in advanced stages of talks and I expect this to be the first big deal that produces royalties and rerates the SP . They could even get an upfront payment for slightly lower royalty payments .

At 9m mkt cap the company is grossly undervalued and any such deal would result Inna very significant rise ,or as they put it inflection point . It's all there just very few picking up on what's going on here .

The options start at 1.4p we have also had director buys recently too . Sit back and be patient this is going to continue upwards and get a big rise on the above deal being announced imo . Weak holders are getting cleared on the way up too . This will be multiples of the current SP later this year imo . 2p is only 40m mkt cap

There have been several dilutive fund raises here between those gaps in the chart making those targets a lot less realistic and not taking them into account . The mkt cap would be far higher than it was at the times of those gaps especially the 91.2p one .

Then there is the fact this has changed from product development to manufacturing and service contracts . Until they can show they can seal major dead and increase revenue the likelihood is the SP won't recover anywhere near those higher targets .

The likelihood of another fund raise before June is also high given the results will require enough cash for a year to avoid a going concern qualification which would add even more dilution to the equation .

Whilst the recent uptrend is welcome relief following several bad years any spikes tend to be short lived with agl . News is overdue on several fronts and they need to get deals signed soon or the questions will be asked if they are ever going to come .

A fund raise in April or may will see the SP start to retreat as it

Rampers out in force but the SP falls and the rns today wasn't great . Points to another fund raise soon to get the June results signed off without a going concern qualification again like last year ..

Lots of news overdue or due but that sometimes means it's not coming at all ,which has been a common theme with agl over the years .

Still in the game just but with every fund raise that goes by and the years pass by too the chances of success lessen as the competition grow in size and number .

We have heard far more positive news from AN over the years that led to nothing usually when things go quiet or late it means they aren't coming .

Ii will wait to see what the next fund raise brings but revenues are growing at a snails pace rather than the hockey stick growth AN said years ago now .

Be trying to figure out the best time to sell . Too early and miss out on multiples . There always remains risk too but for me this looks fantastic value and has a great chance of success and all for 7m mkt cap currently .

There was a 10m trade earlier in the day ,possibly a rollover but hard to say what they both are really . We will never know for sure .

As for SP I would be minded to look at the mkt cap v revenues for a while ,whilst there is huge potential here some reality needs to be maintained .

1p sp is 16m mkt cap personally I think it's currently worth somewhere in the region of 15-20m until we see further deals and it approach break even

If/when they start signing bigger deals with the likes of Unilever and AZ we will need to see on what terms to get a sense of where the SP will go but I suspect multiples of 1p on a big deal with any of the majors .

From there once profitable and signing big deals the sky is the limit but for now I would like to see them hit break even later this year whilst working upto deals with the big players

Either way at 0.4p it looks ridiculously cheap and could well move fast on any positive news . The hard part here will

I wouldn't get too excited this was already known tbh and the bigger problem is that gdr will require funding in the very near future . . The SP will start to drift quite quickly once they approach the city and with revenues not increasing very much at all it could take 2 or 3 more fund raises before they break even . . This news won't help them raise funds at a decent level only the FDA news may do that and it's not die until then next fund raise comes imo . This is why there are so many short term traders here ,they know that funding is a big issue and likely to tank the SP when it comes

At this point it's a gamble and nobody knows the outcome . The fact no rns has come on the funding suggests there is something being discussed for sure but until it's announced it's at as much risk of failing too . Try to recall other companies in dire straights being in talks only for them to fail and the companies entering admin .

It's a pure gamble at this stage and nobody knows the outcome pure and simple . Place your bets it's red or black this one ,anyone suggesting the odds are better than that is a ramper or deramper nothing more